Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].
[1]. Mohd N Mansoori, et al. Methoxyisoflavones Formononetin and Isoformononetin Inhibit the Differentiation of Th17 Cells and B-cell Lymphopoesis to Promote Osteogenesis in Estrogen-Deficient Bone Loss Conditions. Menopause
















